Non-invasive rapid assessment of chronic liver disease using Magnetic Resonance Imaging with LiverMultiScan

Project Information

RADIcAL

Grant agreement ID: 719445

DOI 10.3030/719445

Project closed

EC signature date 21 June 2016

Start date 1 July 2016

End date 31 December 2020

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost € 3 460 486,50

EU contribution € 3 460 486,50

Coordinated by

PERSPECTUM LTD
United Kingdom

Deliverables

Documents, reports (8)

Draft of manuscript for peer-review on baseline and follow-up MRI data.

Draft of manuscript(s) for peer-review on baseline and follow-up MRI data (for participants with both datasets). In addition to evaluation of: - Patient-reported outcome measures on post COVID-19 recovery management (using Dyspnea-12, St Georges Respiratory Questionnaire and the EQ-5D-5L) - Difference in the change in these MR derived biomarkers in those with known genetic variants associated with multi-organ disease (such as PNPLA3) and those without after SARS-CoV-2 infection. - Contextualisation of results using our existing data from the UK Biobank, which includes quantitative MRI with LiverMultiScan®.

SOP for data protection

Standard Operating Procedure for the protection of medical data, in accordance with current EU (Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001, Commision Directive 2005/28/EC, 8 April 2005) and national legislation.

Report on the first 100 COVERSCAN baseline MRI scans

Report on the first 100 baseline MRI scans of participants, covering: organ volume, fat infiltration and fibro-inflammation in kidney, liver, heart, pancreas and spleen; together with biochemical, haematological and immunological measures.

Report on all 507 COVERSCAN baseline MRI scans

Report on all 507 baseline MRI scans of participants, covering: organ volume, fat infiltration and fibro-inflammation in kidney, liver, heart, pancreas and spleen; together with biochemical, haematological and immunological measures.

Report on changes in the organ-specific MRI biomarkers from cohort of participants with 6-month follow-up data

Report on changes in the organ-specific MRI biomarkers from cohort of participants with 6-month follow-up data.

Final Updated Communication Plan

Communication plan to be updated to include new sites, principal investigators and other updated information as necessary

Data management plan

Data management plan.

Communication plan and updates

Communication plan and updates devliered at: -M12 -M24 -M36

Publications

Conference proceedings (3)

CHARACTERIZATION OF MAGNETIC RESONANCE-DERIVED BIOMARKERS OF LIVER HEALTH IN A EUROPEAN COHORT WITH METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE: INTERIM ANALYSIS OF AN ONGOING PROSPECTIVE TRIAL (RADICAL1)

Author(s): Shumbayawonda, E., Mouchti, S., Castelo-Branco, M., Caseiro Alves, F., Coenraad, M., Lamb, H., Beer, M., Schaapman, J., Costa, T., Thomaides-Brears, H., Kelly, M., Rymell, S., French, M., Jenkins, L., Waddell, T., Herdman, L., Tonev, D., Neubauer, S., Banerjee, R., Dollinger, M.
Published in: Gastroenterology, Issue 158(6), S1, 2020, Page(s) S-1292
Publisher: Elsevier

Non-alcoholic fatty liver disease (NAFLD) associates with higher risk of developing symptomatic COVID19 infection - Initial UK Biobank Observations

Author(s): Roca-Fernández, A., Dennis, A., Nicholls, R., McGonigle, J., Kelly, M., Banerjee, R., Sanyal, A. J.
Published in: Hepatology, Issue 72/S1, 2020, Page(s) 1A-130A
Publisher: John Wiley & Sons Inc.

Characterization of MR derived biomarkers of liver health in a European cohort with metabolic syndrome and NAFLD in comparison to healthy controls: Preliminary analysis of an ongoing prospective trial (RADIcAL1).

Author(s): Thomaides-Brears, H.B., Shumbayawonda, E., Mouchti, S., Castelo-Branco, M., Caseiro Alves, F., Coenraad, M., Lamb, H., Beer, M., Schaapman, J., Costa, T., Kelly, M., Rymen, S., Herdman, L., Waddell, T., Neubauer, S., Banerjee, R., Dollinger, M.
Published in: Hepatology, Issue 70/S1, 2019, Page(s) 188-1382, ISSN 0270-9139
Publisher: John Wiley & Sons Inc.

Peer reviewed articles (1)

The Effect of Multi-Parametric Magnetic Resonance Imaging in Standard of Care for Nonalcoholic Fatty Liver Disease: Protocol for a Randomized Control Trial

Author(s): Dimitar Tonev, Elizabeth Shumbayawonda, Louise Ann Tetlow, Laura Herdman, Marika French, Soubera Rymell, Helena Thomaides-Brears, Filipe Caseiro-Alves, Miguel Castelo-Branco, Carlos Ferreira, Minneke Coenraad, Hildo Lamb, Meinrad Beer, Matt Kelly, Rajarshi Banerjee, Matthias Dollinger
Published in: JMIR Research Protocols, Issue 9/10, 2020, Page(s) e19189, ISSN 1929-0748
Publisher: JMIR Publications
DOI: 10.2196/19189

Other (2)

High Liver Fat Associates with Higher Risk of Developing Symptomatic COVID-19 Infection - Initial UK Biobank Observations

Author(s): Roca-Fernández,A., Dennis, A., Nicholls,R., McGonigle,J., Kelly,M., Banerjee, R.
Published in: medRxiv, Issue 05/06/2020, 2020
Publisher: medRvix
DOI: 10.1101/2020.06.04.20122457

Multi-organ impairment in low-risk individuals with long COVID

Author(s): Dennis, A., Wamil, M., Kapur, S., Alberts, J., Badley, A., Decker, G., Rizza, S., Banerjee, R., Banerjee, A.
Published in: medRxiv, Issue 16/10/2020, 2020
Publisher: medRxiv
DOI: 10.1101/2020.10.14.20212555